Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

82.05
BATS BZX Real-Time Price
As of 12:41pm ET
 -3.26 / -3.82%
Today’s Change
41.67
Today|||52-Week Range
86.10
+76.91%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close85.31
Today’s open82.98
Day’s range80.16 - 83.95
Volume16,777
Average volume (3 months)514,944
Market cap$3.2B
Data as of 12:41pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)-14.65%
Earnings growth (this year)+28.39%
Earnings growth (next 5 years)-55.30%
Revenue growth (last year)+1,863.91%
P/E ratioNM
Price/Sales753.82
Price/Book7.41

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.20-1.08%
LOXOLoxo Oncology Inc+6.61+3.70%
FOLDAmicus Therapeutics ...-0.39-2.28%
SUPNSupernus Pharmaceuti...-0.70-1.21%
Data as of 12:43pm ET, 06/21/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$2.07
Annual revenue (last year)$2.6M
Annual profit (last year)-$302.1M
Net profit margin-11,567.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
Chief Financial Officer &
Executive Vice President
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts